Prospective TDM Arm
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Fungal Infection
Conditions
Fungal Infection
Trial Timeline
Jan 1, 2012 → Dec 1, 2014
NCT ID
NCT01416025About Prospective TDM Arm
Prospective TDM Arm is a approved stage product being developed by Pfizer for Fungal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT01416025. Target conditions include Fungal Infection.
What happened to similar drugs?
8 of 20 similar drugs in Fungal Infection were approved
Approved (8) Terminated (4) Active (10)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01416025 | Approved | Completed |
Competing Products
20 competing products in Fungal Infection